510(k) Report

FDA product code · Radiology

Radiology Software For Referral Of Findings Related To Fibrotic Lung Disease.

QWOClass II21 CFR 892.2085510(k) required4 decisions since 20240 recalls

4 FDA decisions since 2024. 510(k) reviews decided 2021–2025 took a median of 130 days (half between 126 and 163). No recall names this code. The most-cited predicate is DEN220040, named by 3 later devices.

Radiology software for referral of findings related to fibrotic lung disease is a prescription image processing device that analyzes computed tomography images to suggest the presence of disease or of an imaging finding suggestive of disease. The output of this device is intended to be used as adjunctive information as part of a referral pathway in the overall diagnostic assessment process.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, radiology panel

Twenty years of QWO at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · QWO

2in 2025

2024: 22025: 2
2007high 2 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QWO

Too few QWO 510(k)s in any year since 2007 to give a median.

Recalls per year · QWO

No recall names QWO since 2007.

Adverse event reports per year · QWO

No MAUDE report names QWO since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20242—00
20252—00
20260—0—
FIG. 1 — QWO by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in QWO? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report